Issue link: https://www.e-digitaleditions.com/i/1481142
Technical articles discuss local treatment of non-small-cell lung cancer (NSCLC) by dry powder inhaler and focus on dry powder inhalers with a brief history and a new look at what may be next. The Cross-industry organizations column provides an update from The Organizers of the Respiratory Drug Delivery Conference Series. The Back pages articles discuss large studies of SABA inhaler overuse. The issue also includes a preview of the Drug Delivery to the Lungs Conference. 2 OCTOBER 2021 Inhalation Inhalation (ISSN 1937-0717 print; ISSN 1940-414X online) is published seven times per year in January, February, April, June, August, October and December by Whipsnade and Loophole, LLC, P.O. Box 27092, Minneapolis, MN 55427 US. w w w . i n h a l a t i o n m a g . c o m October 2022 Volume 16 Number 5 The cover photo shows a high-speed, unit-dose, nasal spray assembly line. Courtesy of Renaissance Lakewood, 1200 Paco Way, Lakewood, New Jersey, 08701, US, Tel.: +1 732 367- 9000, www.renpharm.com devices 10 Local treatment of non-small-cell lung cancer (NSCLC) by dry powder inhaler Kimberly B. Shepard and Maureen Kadleck 17 Issue focus: Devices 22 Dry powder inhalers: A new look at what may be next 24 Dry powder inhalers—More than 170 years of development; Where to next? Mark J. Sanders and Alexis Harper outsourcing services 32 Special section: Outsourcing services additional features 6 Cross-industry organizations: A review of RDD ® 2022 and look ahead to RDD Europe 2023 The Organizers of the Respiratory Drug Delivery Conference Series 9 A preview of Drug Delivery to the Lungs (DDL) 2022 38 Back pages: Study of more than one million patients adds to evidence of SABA overuse Study of SABA over-prescribing suggests improvements and support tools departments 8 Industry news 35 Respiratory medicine news 35 Calendar 36 White papers